Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EscharEx (EX-02) in Basal Cell Carcinoma
NCT05157763Phase 2Unknown
- Sponsor
- MediWound
- Start
- Jun 2021
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of EscharEx in basal cell carcinoma (BCC), sponsored by MediWound. Status: unknown.
02
Drugs
EscharEx
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT05157763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157763.